骨髓增生性肿瘤-话题@MedSci

#骨髓增生性肿瘤#

17篇内容 | 930人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1351326, encodeId=9b43135132626, content=<a href='/topic/show?id=435e10196e86' target=_blank style='color:#2F92EE;'>#骨髓增生性肿瘤#</a>, objectTitle=Leukemia ：罗特西普用于骨髓增生异常综合征/骨髓增生性肿瘤伴环状铁粒幼细胞和血小板增多症, objectType=article, longId=299893, objectId=d33a2998931b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d33a2998931b, replyNumber=0, likeNumber=26, createdTime=2022-03-03, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d33a2998931b, moduleTitle=Leukemia ：罗特西普用于骨髓增生异常综合征/骨髓增生性肿瘤伴环状铁粒幼细胞和血小板增多症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d33a2998931b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351325, encodeId=7681135132543, content=<a href='/topic/show?id=435e10196e86' target=_blank style='color:#2F92EE;'>#骨髓增生性肿瘤#</a>, objectTitle=AJH：脑静脉血栓形成和骨髓增生性肿瘤：74 例连续病例的三中心研究, objectType=article, longId=292083, objectId=782c292083cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=782c292083cf, replyNumber=0, likeNumber=0, createdTime=2021-12-18, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=782c292083cf, moduleTitle=AJH：脑静脉血栓形成和骨髓增生性肿瘤：74 例连续病例的三中心研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=782c292083cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351324, encodeId=9056135132493, content=<a href='/topic/show?id=435e10196e86' target=_blank style='color:#2F92EE;'>#骨髓增生性肿瘤#</a>, objectTitle=Nature：骨髓增生性肿瘤是如何具有遗传性的？, objectType=article, longId=202243, objectId=4384202243ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4384202243ef, replyNumber=0, likeNumber=0, createdTime=2020-10-19, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4384202243ef, moduleTitle=Nature：骨髓增生性肿瘤是如何具有遗传性的？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4384202243ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351323, encodeId=aa2c1351323dd, content=<a href='/topic/show?id=435e10196e86' target=_blank style='color:#2F92EE;'>#骨髓增生性肿瘤#</a>, objectTitle=EClinical Medicine：骨髓增生性肿瘤患者炎症性黄斑变性风险增加, objectType=article, longId=200469, objectId=e57220046940, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e57220046940, replyNumber=0, likeNumber=35, createdTime=2020-09-11, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e57220046940, moduleTitle=EClinical Medicine：骨髓增生性肿瘤患者炎症性黄斑变性风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e57220046940)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351322, encodeId=e5d2135132275, content=<a href='/topic/show?id=435e10196e86' target=_blank style='color:#2F92EE;'>#骨髓增生性肿瘤#</a>, objectTitle=Blood：HDAC11抑制剂，骨髓增生性肿瘤的新选择, objectType=article, longId=183497, objectId=462318349ea8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=462318349ea8, replyNumber=0, likeNumber=37, createdTime=2019-11-25, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=462318349ea8, moduleTitle=Blood：HDAC11抑制剂，骨髓增生性肿瘤的新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=462318349ea8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351321, encodeId=ba45135132123, content=<a href='/topic/show?id=435e10196e86' target=_blank style='color:#2F92EE;'>#骨髓增生性肿瘤#</a>, objectTitle=Blood：巨核细胞钙网蛋白与SOCE的互作异常促进骨髓增生性肿瘤的发生发展, objectType=article, longId=182023, objectId=7fa61820234e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fa61820234e, replyNumber=0, likeNumber=37, createdTime=2019-10-29, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fa61820234e, moduleTitle=Blood：巨核细胞钙网蛋白与SOCE的互作异常促进骨髓增生性肿瘤的发生发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fa61820234e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351320, encodeId=f70f1351320b9, content=<a href='/topic/show?id=435e10196e86' target=_blank style='color:#2F92EE;'>#骨髓增生性肿瘤#</a>, objectTitle=Blood：骨髓增生性肿瘤免疫疗法的新靶点！, objectType=article, longId=166015, objectId=71351660155f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71351660155f, replyNumber=0, likeNumber=42, createdTime=2019-05-15, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71351660155f, moduleTitle=Blood：骨髓增生性肿瘤免疫疗法的新靶点！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71351660155f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351319, encodeId=ee9e13513199e, content=<a href='/topic/show?id=435e10196e86' target=_blank style='color:#2F92EE;'>#骨髓增生性肿瘤#</a>, objectTitle=Blood：CDK 6与骨髓增生性肿瘤, objectType=article, longId=164245, objectId=7e4816424526, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e4816424526, replyNumber=0, likeNumber=43, createdTime=2019-04-15, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e4816424526, moduleTitle=Blood：CDK 6与骨髓增生性肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e4816424526)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351318, encodeId=c9dc135131882, content=<a href='/topic/show?id=435e10196e86' target=_blank style='color:#2F92EE;'>#骨髓增生性肿瘤#</a>, objectTitle=Blood：Sos1缺陷可缓解致瘤性Kras[G12D]所诱导的骨髓增生性肿瘤, objectType=article, longId=152683, objectId=d3ff1526838c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3ff1526838c, replyNumber=0, likeNumber=29, createdTime=2018-11-04, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3ff1526838c, moduleTitle=Blood：Sos1缺陷可缓解致瘤性Kras[G12D]所诱导的骨髓增生性肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3ff1526838c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351317, encodeId=a840135131e2e, content=<a href='/topic/show?id=435e10196e86' target=_blank style='color:#2F92EE;'>#骨髓增生性肿瘤#</a>, objectTitle=NEJM：骨髓增生性肿瘤的分类及个体化预后, objectType=article, longId=150868, objectId=55451508688e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55451508688e, replyNumber=0, likeNumber=53, createdTime=2018-10-14, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55451508688e, moduleTitle=NEJM：骨髓增生性肿瘤的分类及个体化预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55451508688e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351316, encodeId=cd4e13513163f, content=<a href='/topic/show?id=435e10196e86' target=_blank style='color:#2F92EE;'>#骨髓增生性肿瘤#</a>, objectTitle=Blood：特异性敲除骨髓ABI1可诱导类似人类骨髓纤维化的骨髓增生性肿瘤, objectType=article, longId=148977, objectId=c3b81489e745, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3b81489e745, replyNumber=0, likeNumber=40, createdTime=2018-09-18, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3b81489e745, moduleTitle=Blood：特异性敲除骨髓ABI1可诱导类似人类骨髓纤维化的骨髓增生性肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3b81489e745)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351315, encodeId=314b13513153c, content=<a href='/topic/show?id=435e10196e86' target=_blank style='color:#2F92EE;'>#骨髓增生性肿瘤#</a>, objectTitle=Blood：用JAK1/2抑制剂治疗骨髓增生性肿瘤（MPN）可增加患者恶性B细胞淋巴瘤的发病率, objectType=article, longId=141010, objectId=cb7914101089, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb7914101089, replyNumber=0, likeNumber=30, createdTime=2018-06-20, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb7914101089, moduleTitle=Blood：用JAK1/2抑制剂治疗骨髓增生性肿瘤（MPN）可增加患者恶性B细胞淋巴瘤的发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb7914101089)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351314, encodeId=a61e1351314d1, content=<a href='/topic/show?id=435e10196e86' target=_blank style='color:#2F92EE;'>#骨髓增生性肿瘤#</a>, objectTitle=IGLH：JAK2或CALR突变的共存是骨髓增生性肿瘤临床上重要的事件？, objectType=article, longId=139536, objectId=a6da1395367c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6da1395367c, replyNumber=0, likeNumber=36, createdTime=2018-06-01, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6da1395367c, moduleTitle=IGLH：JAK2或CALR突变的共存是骨髓增生性肿瘤临床上重要的事件？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6da1395367c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351313, encodeId=380c13513134b, content=<a href='/topic/show?id=435e10196e86' target=_blank style='color:#2F92EE;'>#骨髓增生性肿瘤#</a>, objectTitle=Blood：JAK2抑制剂用于治疗骨髓增生性肿瘤（MFN）的效果和安全性评估, objectType=article, longId=135312, objectId=411e1353128b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=411e1353128b, replyNumber=0, likeNumber=46, createdTime=2018-04-15, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=411e1353128b, moduleTitle=Blood：JAK2抑制剂用于治疗骨髓增生性肿瘤（MFN）的效果和安全性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=411e1353128b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351312, encodeId=83e71351312b5, content=<a href='/topic/show?id=435e10196e86' target=_blank style='color:#2F92EE;'>#骨髓增生性肿瘤#</a>, objectTitle=Blood：调控骨髓增生性肿瘤过表达NFE2的两种新型表观遗传通路, objectType=article, longId=131940, objectId=15ff13194056, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15ff13194056, replyNumber=0, likeNumber=39, createdTime=2018-03-11, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15ff13194056, moduleTitle=Blood：调控骨髓增生性肿瘤过表达NFE2的两种新型表观遗传通路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15ff13194056)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351311, encodeId=190b13513117c, content=<a href='/topic/show?id=435e10196e86' target=_blank style='color:#2F92EE;'>#骨髓增生性肿瘤#</a>, objectTitle=Blood：在骨髓增生性肿瘤中，突变型钙网蛋白与MPL之间的致病性的相互作用。, objectType=article, longId=125270, objectId=b34b1252e09e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b34b1252e09e, replyNumber=0, likeNumber=34, createdTime=2018-01-03, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b34b1252e09e, moduleTitle=Blood：在骨髓增生性肿瘤中，突变型钙网蛋白与MPL之间的致病性的相互作用。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b34b1252e09e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1351310, encodeId=c6ff135131088, content=<a href='/topic/show?id=435e10196e86' target=_blank style='color:#2F92EE;'>#骨髓增生性肿瘤#</a>, objectTitle=2017 日本造血和淋巴组织肿瘤指南：慢性粒细胞白血病/骨髓增生性肿瘤, objectType=article, longId=115285, objectId=810a1152853d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=810a1152853d, replyNumber=0, likeNumber=35, createdTime=2017-10-07, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=810a1152853d, moduleTitle=2017 日本造血和淋巴组织肿瘤指南：慢性粒细胞白血病/骨髓增生性肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=810a1152853d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

骨髓增生性肿瘤

2020-05-29

zhaojie88 (审核中...)

前往app查看评论内容

#骨髓增生性肿瘤#

Leukemia ：罗特西普用于骨髓增生异常综合征/骨髓增生性肿瘤伴环状铁粒幼细胞和血小板增多症

2022-03-03

zhaojie88 (审核中...)

前往app查看评论内容

#骨髓增生性肿瘤#

AJH：脑静脉血栓形成和骨髓增生性肿瘤：74 例连续病例的三中心研究

2021-12-18

zhaojie88 (审核中...)

前往app查看评论内容

#骨髓增生性肿瘤#

Nature：骨髓增生性肿瘤是如何具有遗传性的？

2020-10-19

zhaojie88 (审核中...)

前往app查看评论内容

#骨髓增生性肿瘤#

EClinical Medicine：骨髓增生性肿瘤患者炎症性黄斑变性风险增加

2020-09-11

zhaojie88 (审核中...)

前往app查看评论内容

#骨髓增生性肿瘤#

Blood：HDAC11抑制剂，骨髓增生性肿瘤的新选择

2019-11-25

zhaojie88 (审核中...)

前往app查看评论内容

#骨髓增生性肿瘤#

Blood：巨核细胞钙网蛋白与SOCE的互作异常促进骨髓增生性肿瘤的发生发展

2019-10-29

zhaojie88 (审核中...)

前往app查看评论内容

#骨髓增生性肿瘤#

Blood：骨髓增生性肿瘤免疫疗法的新靶点！

2019-05-15

zhaojie88 (审核中...)

前往app查看评论内容

#骨髓增生性肿瘤#

Blood：CDK 6与骨髓增生性肿瘤

2019-04-15

zhaojie88 (审核中...)

前往app查看评论内容

#骨髓增生性肿瘤#

Blood：Sos1缺陷可缓解致瘤性Kras[G12D]所诱导的骨髓增生性肿瘤

2018-11-04

zhaojie88 (审核中...)

前往app查看评论内容

#骨髓增生性肿瘤#

NEJM：骨髓增生性肿瘤的分类及个体化预后

2018-10-14

zhaojie88 (审核中...)

前往app查看评论内容

#骨髓增生性肿瘤#

Blood：特异性敲除骨髓ABI1可诱导类似人类骨髓纤维化的骨髓增生性肿瘤

2018-09-18

zhaojie88 (审核中...)

前往app查看评论内容

#骨髓增生性肿瘤#

Blood：用JAK1/2抑制剂治疗骨髓增生性肿瘤（MPN）可增加患者恶性B细胞淋巴瘤的发病率

2018-06-20

zhaojie88 (审核中...)

前往app查看评论内容

#骨髓增生性肿瘤#

IGLH：JAK2或CALR突变的共存是骨髓增生性肿瘤临床上重要的事件？

2018-06-01

zhaojie88 (审核中...)

前往app查看评论内容

#骨髓增生性肿瘤#

Blood：JAK2抑制剂用于治疗骨髓增生性肿瘤（MFN）的效果和安全性评估

2018-04-15

zhaojie88 (审核中...)

前往app查看评论内容

#骨髓增生性肿瘤#

Blood：调控骨髓增生性肿瘤过表达NFE2的两种新型表观遗传通路

2018-03-11

zhaojie88 (审核中...)

前往app查看评论内容

#骨髓增生性肿瘤#

Blood：在骨髓增生性肿瘤中，突变型钙网蛋白与MPL之间的致病性的相互作用。

2018-01-03

zhaojie88 (审核中...)

前往app查看评论内容

#骨髓增生性肿瘤#

2017 日本造血和淋巴组织肿瘤指南：慢性粒细胞白血病/骨髓增生性肿瘤

2017-10-07

科室
- - 订阅+
  - 更多科室
工具
服务